Although vaccination programmes against pertussis are very effective in Europe, new Finnish study shows that the disease is still very common among middle-aged adults in various European countries. At the same time, the results show that the disease is underdiagnosed as the annually reported figures are considerably lower than those discovered in the study.
Finland's two-year term as the Chair of the Conservation of Arctic Flora and Fauna (CAFF) working group of the Arctic Council starts in May 2021. Docent in Environmental Ecology, PhD Mia Rönkä from the Biodiversity Unit at the University of Turku and Natural Resources Institute Finland will start as the Chair.
Contracts are fundamental for today’s networked business practices. Various professionals plan, design, and implement contracts, yet many of them find contracts difficult or even impossible to understand. In addition, contracts are mostly designed to protect parties in case something goes wrong––not to support collaboration.
Researchers discovered that a large amount of enterobacteria in the gut microbiota is related to long-term mortality risk in Finnish adult population.
A Finnish study coordinated by the Research Centre of Applied and Preventive Cardiovascular Medicine at the University of Turku shows that exposure to cardiovascular risk factors, such as high blood pressure, elevated serum cholesterol, and obesity, from childhood to midlife are associated with poor cognitive performance in midlife. Importantly, the worse the cardiovascular risk factor profile and the higher the number of the risk factors was, the poorer cognitive performance was observed.
Children born in December are almost twice as likely to be diagnosed with a learning disorder as those born in January. ADHD was found not to affect the association between month of birth and the likelihood of a learning disability diagnosis.
Professor André Sourander has received substantial research funding from the European Research Council (ERC). Sourander received ERC Advanced Grant funding for a project “DIGIPARENT - Implementation, personalization and genetics of digitally assisted parent training intervention to improve child mental health services.
Notch proteins are key regulators of growth and differentiation of both normal and cancer cells. Researchers in Turku, Finland, have now demonstrated that the activities of distinct Notch family members are modified differently by phosphorylation. These results can be used in the development of new cancer treatments, especially for hormone-dependent breast cancer.
Docent Juha Laine has been appointed as Professor of Practice in Pharmacoeconomics and Dr. Timo Veromaa Professor of Practice in Drug Development. The appointments strengthen the operations of the InFLAMES Flagship, joint effort of the University of Turku and Åbo Akademi University, funded by the Academy of Finland. Both professors of practice have been offered part-time positions for the duration of the InFLAMES Flagship funding period.
The preliminary trial results of a novel radiopharmaceutical for PET imaging of inflammation developed at the University of Turku, Finland, have been published. The compound, which targets the vascular adhesion protein 1 (VAP-1) that regulates inflammatory cell traffic, is the first radiopharmaceutical that has been developed completely in Finland and has advanced to clinical trials. In the study that started with healthy volunteers, the radiopharmaceutical was found to be well tolerated and safe.